VYNE Therapeutics Inc. (VYNE) Net Income by Year
VYNE Therapeutics Inc. reported a net loss of $26.5M in fiscal year 2025. This represents an increase of 33.5% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters VYNE Therapeutics Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VYNE Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
VYNE Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More VYNE Therapeutics Inc. financials
Frequently Asked Questions
What was VYNE Therapeutics Inc.'s net income in fiscal year 2025?
VYNE Therapeutics Inc. reported a net loss of $26.5M in fiscal year 2025.
How fast is VYNE Therapeutics Inc.'s net income growing?
VYNE Therapeutics Inc. (VYNE) net income rose by 33.5% year over year, from -$39.8M to -$26.5M in fiscal year 2025.
How has VYNE Therapeutics Inc.'s net income changed over the years?
Across the 11 fiscal years this page covers, VYNE Therapeutics Inc. (VYNE) net income went from -$4.6M in fiscal year 2015 to -$26.5M in fiscal year 2025.
What was VYNE Therapeutics Inc.'s net income in the most recent quarter?
VYNE Therapeutics Inc. (VYNE) reported -$3.0M in net income in Q2 2026. This represents an increase of 47.7% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what VYNE Therapeutics Inc. (VYNE) reported on that line in every period on record.